Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-03-20)

USD 19.87-2.69%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

3.20 10 votes No rating yet

NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-48.9%1Y

-49.1%3Y

-84.1%5Y

Performance

78.8%1Y

58.6%3Y

56.8%5Y

Volatility

1920 M

Market cap (USD)

3,797,567

Daily traded volume (Shares)

43.045 / 41.53

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.20

10 votes

Performance:

3.50

Innovation:

3.60

Society:

3.40

Nature:

3.10

oliver baigel

United Kingdom, 09 Nov 2025

a very low performing stock with a high level of risk

Yam Yi Pan

United Kingdom, 08 Nov 2025

1

Misha Batvinov

United Kingdom, 07 Nov 2025

ok

EQUITIES OF THE SAME SECTOR

Tecan Group Ltd.

Tecan Group Ltd. Valor: 1210019

Annual Return

-50%0%+50%

Risk level

110

-1.78%CHF 116.10

Neumora Therapeutics Inc

Neumora Therapeutics Inc Valor: 129329732

Annual Return

-50%0%+50%

Risk level

110

-2.33%USD 2.51

Elevance Health Inc

Elevance Health Inc Valor: 26124340

Annual Return

-50%0%+50%

Risk level

110

0.11%USD 291.48

L'Oreal S.A.

L'Oreal S.A. Valor: 502805

Annual Return

-50%0%+50%

Risk level

110

0.70%EUR 347.70

Xvivo Perfusion AB

Xvivo Perfusion AB Valor: 19661174

Annual Return

-50%0%+50%

Risk level

110

1.33%SEK 183.00

Formycon AG

Formycon AG Valor: 12194189

Annual Return

-50%0%+50%

Risk level

110

1.43%EUR 17.06

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

-5.61%CHF 1.01

Dynavox Group AB

Dynavox Group AB Valor: 114900704

Annual Return

-50%0%+50%

Risk level

110

-4.55%SEK 79.70

Hims & Hers Health Inc

Hims & Hers Health Inc Valor: 59397181

Annual Return

-50%0%+50%

Risk level

110

-8.86%USD 22.02

SOLVENTUM CORP

SOLVENTUM CORP Valor: 133635906

Annual Return

-50%0%+50%

Risk level

110

-2.03%USD 65.78

SIX

FactSet

Clearbit

Logos provided by Clearbit